메뉴 건너뛰기
Japanese Journal of Gastroenterology
Volumn 105, Issue 3, 2008, Pages 367-372
Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) for metastatic liver tumors in patients with gastric cancer
Author keywords

[No Author keywords available]
Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DEGRADABLE STARCH MICROSPHERE; IRINOTECAN; MITOMYCIN; PACLITAXEL; STARCH MICROSPHERE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MICROSPHERE; STARCH;
EID: 42949176199     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (16)
References (20)
  • 1
    • 0017121625 scopus 로고
    • Temporary intestinal hypoxia induced by degradable microspheres
    • Arfors KE, Forsberg JO, Larsson B, et al: Temporary intestinal hypoxia induced by degradable microspheres. Nature 262;500-501:1976
    • (1976) Nature , vol.262 , pp. 500-501
    • Arfors, K.E.1    Forsberg, J.O.2    Larsson, B.3
  • 2
    • 0021266057 scopus 로고
    • Enhanced drug retention in VX2 tumors by use of degradable starch microspheres
    • Lorelius LE, Benedetto AR, Blumhardt R, et al: Enhanced drug retention in VX2 tumors by use of degradable starch microspheres. Invest Radiol 19;212-215:1984
    • (1984) Invest Radiol , vol.19 , pp. 212-215
    • Lorelius, L.E.1    Benedetto, A.R.2    Blumhardt, R.3
  • 3
    • 0022981043 scopus 로고
    • Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptake
    • Sigurdson ER, Ridge JA, Daly JM, et al: Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptake. Arch Surg 121;1277-1281:1986
    • (1986) Arch Surg , vol.121 , pp. 1277-1281
    • Sigurdson, E.R.1    Ridge, J.A.2    Daly, J.M.3
  • 4
    • 0018852436 scopus 로고
    • Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells
    • Kennedy KA, Rockwell S, Sartorelli AC, et al: Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 40;2356-2360:1980
    • (1980) Cancer Res , vol.40 , pp. 2356-2360
    • Kennedy, K.A.1    Rockwell, S.2    Sartorelli, A.C.3
  • 5
    • 77955166696 scopus 로고    scopus 로고
    • Japanese source
  • 6
    • 0018634795 scopus 로고
    • Controlled blocking of hepatic artery flow with enzymatically degradable microspheres combined with oncolytic drugs
    • Aronsen KF, Hellekant C, Holmberg J, et al: Controlled blocking of hepatic artery flow with enzymatically degradable microspheres combined with oncolytic drugs. Eur Surg Res 11;99-106:1979
    • (1979) Eur Surg Res , vol.11 , pp. 99-106
    • Aronsen, K.F.1    Hellekant, C.2    Holmberg, J.3
  • 7
    • 77955128397 scopus 로고    scopus 로고
    • Japanese source
  • 8
    • 77955151162 scopus 로고    scopus 로고
    • Japanese source
  • 9
    • 77955127407 scopus 로고    scopus 로고
    • Japanese source
  • 10
    • 77955164086 scopus 로고    scopus 로고
    • Japanese source
  • 11
    • 77955142892 scopus 로고    scopus 로고
    • Japanese source
  • 12
    • 77955146172 scopus 로고    scopus 로고
    • Japanese source
  • 13
    • 0032919992 scopus 로고    scopus 로고
    • Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer
    • Boku N, Ohtsu A, Shimada Y, et al: Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol 17;319-323:1999
    • (1999) J Clin Oncol , vol.17 , pp. 319-323
    • Boku, N.1    Ohtsu, A.2    Shimada, Y.3
  • 14
    • 77955169006 scopus 로고    scopus 로고
    • Japanese source
  • 15
    • 0034029776 scopus 로고    scopus 로고
    • Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer
    • For the S-1 Cooperative Gastric Cancer Study Group
    • Koizumi W, Kurihara M, Nakano S, et al: Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group. Oncology 58;191-197:2000
    • (2000) Oncology , vol.58 , pp. 191-197
    • Koizumi, W.1    Kurihara, M.2    Nakano, S.3
  • 16
    • 0036143942 scopus 로고    scopus 로고
    • Hepatic resection for metastatic tumors from gastric cancer
    • Okano K, Maeba T, Ishimura K, et al: Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235;86-91:2002
    • (2002) Ann Surg , vol.235 , pp. 86-91
    • Okano, K.1    Maeba, T.2    Ishimura, K.3
  • 17
    • 77955166477 scopus 로고    scopus 로고
    • Japanese source
  • 18
    • 8644236724 scopus 로고
    • Hepatic arterial infusion for unresectable liver metastases form gastric cancer
    • Arai Y, Sone Y, Tohyama N, et al: Hepatic arterial infusion for unresectable liver metastases form gastric cancer. Proc. ASCO 11;176:1992
    • (1992) Proc. ASCO , vol.11 , pp. 176
    • Arai, Y.1    Sone, Y.2    Tohyama, N.3
  • 19
    • 0032861226 scopus 로고    scopus 로고
    • Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer
    • Kumada T, Arai Y, Itoh K, et al: Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer. Oncology 57;216-223:1999
    • (1999) Oncology , vol.57 , pp. 216-223
    • Kumada, T.1    Arai, Y.2    Itoh, K.3
  • 20
    • 77955139299 scopus 로고    scopus 로고
    • Japanese source

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.